In Vitro Study of Kaempferia galanga L. Compound, δ- 3-Carene, Against 5-Lipoxygenase
- https://doi.org/10.2991/ahsr.k.210115.088How to use a DOI?
- Kaempferia galanga, Anti-inflammatory, lipoxygenase, δ-3-carene
Kaempferia galanga has anti-inflammatory activity and worth developing as lipoxygenase inhibitors. The aim of this study was to determined δ-3-carene, one of the potential compounds of K. galanga, as a lipoxygenase inhibitor. The LOX-inhibitor activity was tested in-vitro. The result showed that the IC50 of δ-3-carene was 23.10 µM, which was less potential compare to zileuton (7.54 µM). The study showed that K. galanga contains possible active components that could be developed as 5-LOX-inhibitor.
- © 2021, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - Lusi Putri Dwita AU - Supandi AU - Yeni PY - 2021 DA - 2021/01/16 TI - In Vitro Study of Kaempferia galanga L. Compound, δ- 3-Carene, Against 5-Lipoxygenase BT - Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020) PB - Atlantis Press SP - 443 EP - 444 SN - 2468-5739 UR - https://doi.org/10.2991/ahsr.k.210115.088 DO - https://doi.org/10.2991/ahsr.k.210115.088 ID - Dwita2021 ER -